We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Stoke Therapeutics
STOK
$2.06B
| $4.52M | 0.01% |
135,050
-64,950
| -32% | -$1.85M |
|
652
Bristow Group
VTOL
$1.34B
| $4.46M | 0.01% |
210,102
-189,898
| -47% | -$3.55M |
|
653
Black Diamond Therapeutics
BDTX
$113M
| $4.38M | 0.01% |
+145,000
| New | +$4.41M |
|
654
Unity
U
$19.3B
| $4.36M | 0.01% |
+50,000
| New | +$4.22M |
|
655
Merit Medical Systems
MMSI
$5.23B
| $4.35M | 0.01% |
+100,000
| New | +$4.52M |
|
656
Warner Music
WMG
$13.8B
| $4.31M | 0.01% |
150,000
| – | – |
|
657
Arrowhead Research
ARWR
$12.3B
| $4.31M | 0.01% |
100,000
-25,000
| -20% | -$1.08M |
|
658
Arcus Biosciences
RCUS
$3.64B
| $4.29M | 0.01% |
250,000
| – | – |
|
|
OTIC
659
DELISTED
Otonomy, Inc.
OTIC
| $4.15M | 0.01% |
+1,025,500
| New | +$3.87M |
|
660
Paylocity
PCTY
$8.06B
| $4.04M | 0.01% |
25,000
-10,000
| -29% | -$1.41M |
|
661
Alpha Metallurgical Resources
AMR
$1.91B
| $4.01M | 0.01% |
547,928
+22,928
| +4% | +$106K |
|
|
PROS
662
DELISTED
ProSight Global, Inc.
PROS
| $3.97M | 0.01% |
350,000
+50,000
| +17% | +$462K |
|
|
JNPR
663
DELISTED
Juniper Networks
JNPR
| $3.95M | 0.01% |
183,900
+13,000
| +8% | +$308K |
|
|
QEP
664
DELISTED
QEP RESOURCES, INC.
QEP
| $3.95M | 0.01% |
4,373,050
-890,214
| -17% | -$1.16M |
|
665
Cenovus Energy
CVE
$51.6B
| $3.89M | 0.01% |
1,000,000
-2,350,000
| -70% | -$10.8M |
|
666
Vroom Inc
VRM
$49.1M
| $3.88M | 0.01% |
938
| – | – |
|
|
FARM
667
DELISTED
Farmer Brothers
FARM
| $3.84M | 0.01% |
869,699
| – | – |
|
668
Xerox
XRX
$427M
| $3.79M | 0.01% |
201,800
-6,500
| -3% | -$114K |
|
669
Leidos
LDOS
$16.7B
| $3.71M | 0.01% |
+41,636
| New | +$3.76M |
|
670
GeoPark
GPRK
$613M
| $3.68M | 0.01% |
500,000
+100,000
| +25% | +$926K |
|
671
Ashland
ASH
$3.31B
| $3.65M | 0.01% |
51,503
-425,000
| -89% | -$31.5M |
|
672
Globe Life
GL
$14.3B
| $3.62M | 0.01% |
45,300
-8,600
| -16% | -$686K |
|
|
SUMO
673
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $3.6M | 0.01% |
+165,000
| New | +$3.9M |
|
674
GFL Environmental
GFL
$15.1B
| $3.51M | 0.01% |
+165,000
| New | +$3.32M |
|
|
CFRX
675
DELISTED
ContraFect Corporation
CFRX
| $3.43M | 0.01% |
8,125
| – | – |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.